PureTech Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . PureTech Health PLC
PRTC Stock  USD 16.64  0.35  2.06%   
PureTech Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing PureTech Health's valuation are provided below:
Gross Profit
-48.8 M
Profit Margin
7.9296
Market Capitalization
410.6 M
Enterprise Value Revenue
18.0826
Revenue
6.4 M
We have found one hundred twenty available trending fundamental ratios for PureTech Health PLC, which can be analyzed and compared to other ratios and to its competitors. Investors should ensure to check out all of PureTech Health's recent performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road. As of December 30, 2025, Market Cap is expected to decline to about 643.9 M. In addition to that, Enterprise Value is expected to decline to about 528.1 M

PureTech Health Total Revenue

5.38 Million

Check PureTech Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PureTech Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.9 M, Interest Expense of 6.7 M or Selling General Administrative of 27.2 M, as well as many indicators such as Price To Sales Ratio of 194, Dividend Yield of 2.0E-4 or PTB Ratio of 1.26. PureTech financial statements analysis is a perfect complement when working with PureTech Health Valuation or Volatility modules.
  
Build AI portfolio with PureTech Stock
Check out the analysis of PureTech Health Correlation against competitors.

PureTech Health Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets554 M602.6 M446.2 M
Slightly volatile
Short and Long Term Debt Total26 M22.4 M21 M
Slightly volatile
Total Current Liabilities39.3 M41.4 M116.3 M
Pretty Stable
Property Plant And Equipment Net19.7 M15.1 M15.9 M
Slightly volatile
Accounts Payable8 M5.5 M6.5 M
Slightly volatile
Cash190.2 M280.6 M153.7 M
Slightly volatile
Non Current Assets Total256.3 M216.4 M206.1 M
Slightly volatile
Non Currrent Assets Other452.2 K476 K93.4 M
Slightly volatile
Cash And Short Term Investments283.9 M367.3 M228.9 M
Slightly volatile
Net Receivables13.5 M12.9 M4.4 M
Slightly volatile
Common Stock Total Equity4.6 M4.9 M13.8 M
Pretty Stable
Common Stock Shares Outstanding24 M27 M20 M
Slightly volatile
Liabilities And Stockholders Equity554 M602.6 M446.2 M
Slightly volatile
Non Current Liabilities Total161 M153.3 M63.8 M
Slightly volatile
Other Current Assets7 M6 M5.7 M
Slightly volatile
Other Stockholder Equity257.6 M243.4 M210.5 M
Slightly volatile
Total Liabilities223 M194.7 M181.5 M
Slightly volatile
Property Plant And Equipment Gross24.8 M28 M20 M
Slightly volatile
Total Current Assets297.7 M386.3 M240.2 M
Slightly volatile
Intangible Assets571 K601 K2.2 M
Slightly volatile
Common Stock4.6 M4.9 M13.8 M
Pretty Stable
Other Liabilities26 M27.3 M28.1 M
Slightly volatile
Net Tangible Assets490.8 M622.6 M363.9 M
Slightly volatile
Other Assets0.860.9369.3 K
Pretty Stable
Short and Long Term Debt6.6 M4.1 M7.7 M
Very volatile
Property Plant Equipment28 M50.5 M22.5 M
Slightly volatile
Net Invested Capital543 M418.8 M377.8 M
Slightly volatile
Capital Lease Obligations27.6 M18.2 M12.9 M
Slightly volatile
Capital Stock4.3 M4.9 M5.3 M
Slightly volatile

PureTech Health Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.9 M3.6 M3.2 M
Slightly volatile
Interest Expense6.7 M10 M5.4 M
Slightly volatile
Selling General Administrative27.2 M27.5 M22.2 M
Slightly volatile
Total Revenue5.4 M4.8 M6.8 M
Pretty Stable
Other Operating Expenses114.8 M140.4 M93.7 M
Slightly volatile
Research Development56.5 M54.3 M45.8 M
Slightly volatile
Total Operating Expenses93.2 M140.4 M76.4 M
Slightly volatile
Cost Of Revenue5.4 M5.7 M39.4 M
Slightly volatile
Interest Income23.8 M22.7 M5.5 M
Slightly volatile
Reconciled Depreciation5.9 M3.6 M4 M
Slightly volatile
Selling And Marketing Expenses18.5 M20.9 M22.7 M
Slightly volatile

PureTech Health Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation24 M22.9 M9.7 M
Slightly volatile
Begin Period Cash Flow154.1 M191.1 M124.9 M
Slightly volatile
Depreciation3.9 M3.6 M3.2 M
Slightly volatile
Dividends Paid474.5 K451.9 K209.1 K
Slightly volatile
Capital Expenditures10.4 K11 K2.9 M
Very volatile
End Period Cash Flow176.9 M280.6 M143.1 M
Slightly volatile
Issuance Of Capital Stock850.2 K895 K89.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio194103213
Pretty Stable
Dividend Yield2.0E-41.0E-42.0E-4
Slightly volatile
Days Sales Outstanding1 K975508
Slightly volatile
Stock Based Compensation To Revenue2.544.73282.7381
Pretty Stable
Capex To Depreciation0.00290.00311.621
Slightly volatile
EV To Sales47.1349.6083174
Very volatile
Payables Turnover0.370.394.6417
Pretty Stable
Sales General And Administrative To Revenue7.865.69418.5374
Pretty Stable
Research And Ddevelopement To Revenue15.111.242816.3389
Pretty Stable
Capex To Revenue0.00220.00230.5912
Very volatile
Cash Per Share9.2413.621210.2007
Slightly volatile
Days Payables Outstanding1.3 K1.2 K714
Slightly volatile
Intangibles To Total Assets9.0E-40.0010.0483
Slightly volatile
Current Ratio9.89.33262.8445
Slightly volatile
Receivables Turnover0.360.37427.5944
Slightly volatile
Graham Number3.813.012.8572
Slightly volatile
Capex Per Share4.0E-44.0E-40.1505
Slightly volatile
Revenue Per Share0.170.1790.5147
Slightly volatile
Interest Debt Per Share0.971.20141.0864
Slightly volatile
Debt To Assets0.06470.03710.0613
Slightly volatile
Days Of Payables Outstanding1.3 K1.2 K714
Slightly volatile
Long Term Debt To Capitalization0.0130.01670.0091
Slightly volatile
Total Debt To Capitalization0.04860.05120.1792
Slightly volatile
Quick Ratio9.89.33262.8468
Slightly volatile
Cash Ratio7.126.78071.9022
Slightly volatile
Days Of Sales Outstanding1 K975508
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.241.00011.2424
Slightly volatile
Fixed Asset Turnover0.30.31912.2693
Slightly volatile
Debt Ratio0.06470.03710.0613
Slightly volatile
Price Sales Ratio194103213
Pretty Stable
Asset Turnover0.00760.0080.1131
Slightly volatile

PureTech Health Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap643.9 M700.8 M743.1 M
Slightly volatile
Enterprise Value528.1 M551.6 M625.6 M
Slightly volatile

PureTech Fundamental Market Drivers

PureTech Upcoming Events

26th of April 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About PureTech Health Financial Statements

PureTech Health stakeholders use historical fundamental indicators, such as PureTech Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although PureTech Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in PureTech Health's assets and liabilities are reflected in the revenues and expenses on PureTech Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in PureTech Health PLC. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-26.5 M-25.2 M
Total Revenue4.8 M5.4 M
Cost Of Revenue5.7 M5.4 M
Stock Based Compensation To Revenue 4.73  2.54 
Sales General And Administrative To Revenue 5.69  7.86 
Research And Ddevelopement To Revenue 11.24  15.10 
Revenue Per Share 0.18  0.17 
Ebit Per Revenue(28.19)(29.60)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
DDDupont De Nemours
CRDOCredo Technology Group
GOOGAlphabet Inc Class C
When determining whether PureTech Health PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PureTech Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puretech Health Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puretech Health Plc Stock:
How To Invest In PureTech
Details
Is PureTech Stock a good investment?
Details
What is PureTech Health's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of PureTech Health Correlation against competitors.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PureTech Health. If investors know PureTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PureTech Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.615
Earnings Share
1.7
Revenue Per Share
0.27
Quarterly Revenue Growth
5.427
Return On Assets
(0.13)
The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between PureTech Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if PureTech Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PureTech Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY